Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Illumina Inc (NASDAQ:ILMN)

122.02
Delayed Data
As of 4:14pm ET
 -4.38 / -3.47%
Today’s Change
119.37
Today|||52-Week Range
196.47
-36.43%
Year-to-Date
The Worst American Stocks of 2016
9:28am / MotleyFool.com - Paid Partner Content
3 Ways Pacific Biosciences of California Can Rebound in 2017
Dec 01 / MotleyFool.com - Paid Partner Content
Can Illumina Regain Its Mojo?
Dec 03 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks to Buy on Sale
Nov 29 / MotleyFool.com - Paid Partner Content
MedTech Sails Through Macro Woes: Stocks in Focus
Dec 02 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close126.40
Today’s open123.80
Day’s range119.37 - 124.49
Volume2,506,716
Average volume (3 months)1,341,961
Market cap$18.6B
Dividend yield--
Data as of 4:14pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)+30.80%
Earnings growth (this year)+0.30%
Earnings growth (next 5 years)+11.61%
Revenue growth (last year)+19.25%
P/E ratio40.9
Price/Sales12.89
Price/Book10.02

Competitors

 Today’s
change
Today’s
% change
TECHBio-Techne Corp-1.66-1.53%
NBIXNeurocrine Bioscienc...-2.09-4.64%
XONIntrexon Corp-0.49-1.61%
BLUEbluebird bio Inc-8.45-10.70%
Data as of 4:02pm ET, 12/07/2016

Financials

Next reporting dateJanuary 31, 2017
EPS forecast (this quarter)$0.82
Annual revenue (last year)$2.2B
Annual profit (last year)$461.6M
Net profit margin20.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
EVP, Chief Financial &
Administrative Officer
Marc A. Stapley
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs